News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
218 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25385)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Karolinska Development Publishes Interim Report (January - September 2017) and Reports A Positive Result for the Third Quarter
The company will host a conference call and an online presentation on October 31, at 2 pm CET.
October 31, 2017
·
6 min read
Laser Ablation for Automatic Hypotube Coating Removal and Advanced Surface Treatments
Laser ablation is gaining popularity for medical device applications that require stripping of coatings on cylindrical components like hypotubes and guide wires.
October 31, 2017
·
9 min read
Business
Cumberland Pharmaceuticals to Announce Third Quarter 2017 Financial Results
A conference call and live Internet webcast will be held on Tuesday, November 7, 2017, at 4:30 p.m. Eastern Time to discuss the results.
October 31, 2017
·
2 min read
Biotech Bay
Eiger BioPharma Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriter’s Option to Purchase Additional Shares
The offering was made under the company’s effective shelf registration statement and resulted in net proceeds to the company of approximately $19.5M, after underwriting discounts and commissions and estimated offering expenses.
October 31, 2017
·
2 min read
Business
Dr. Markus Enzelberger Appointed MorphoSys’s Chief Scientific Officer
He will succeed Dr. Marlies Sproll, who has been on temporary leave from her CSO position for family reasons since April 15, 2017.
October 31, 2017
·
3 min read
Business
Masimo Reports Third Quarter 2017 Financial Results
The Company’s worldwide direct product revenue in the third quarter of 2017 increased by $21.7 million compared to the same period in 2016 and represented 87.7% of product revenue.
October 31, 2017
·
12 min read
Business
Senseonics Holdings Reports Third Quarter 2017 Financial Results
Revenue was $2.1 million for the third quarter of 2017, compared to $37,000 for the third quarter of 2016.
October 31, 2017
·
7 min read
Pharm Country
Lupus Research Alliance LuCIN Clinical Trials Network Launches Inaugural Studies
The Lupus Research Alliance today announced the first clinical trials to be conducted through its LuCIN aimed at discovering new treatments for the millions of people around the globe living with lupus.
October 31, 2017
·
4 min read
Drug Development
Mithra Completes Recruitment for Estelle Phase III Study in US & Canada
Mithra today announces the completion of recruitment in the E4 Freedom Phase III study of Estelle in the US and Canada. Estelle is Mithra’s combined oral contraceptive candidate composed of 15 mg Estetrol (E4) and 3 mg drospirenone.
October 31, 2017
·
2 min read
Business
AZTherapies Appoints Karen Reeves, MD As President and CMO
Former Pfizer executive joins AZTherapies.
October 31, 2017
·
5 min read
Previous
12 of 22
Next